Cover Image

Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ruirui Wang, Yonghong Zhang, Yijie Gao, Linan Chen, Xiaoying Chen, Ruth Peters, Craig S. Anderson, Michel Marre, Stephen Harrap, Pavel Hamet, Giuseppe Mancia, Mark Woodward, John Chalmers, Katie Harris
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study
by: Miriam Pikkemaat, et al.
Published: (2024)

The One‐Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational Diabetes
by: Niels Bochanen, et al.
Published: (2026)

Cardiorenal Outcomes of Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic‐Range Proteinuria: A Multi‐Institutional Target Trial Emulation
by: Jia‐Jin Chen, et al.
Published: (2026)

Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
by: Qing Yang, et al.
Published: (2026)

Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis‐Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia
by: Alexandros L. Liarakos, et al.
Published: (2026)

Glycaemic Metrics Improve Significantly Within 7 Days of Continuous Glucose Monitoring Initiation in Non‐Insulin–Using People With Type 2 Diabetes
by: Holly J. Willis, et al.
Published: (2026)

Comparison of Glucose Management Between Open‐Source Loop and Tandem Control‐ IQ Automated Insulin Delivery Systems in Adults With Type 1 Diabetes
by: Zekai Wu, et al.
Published: (2026)

Patterns and Trends of Glucose‐Lowering Therapy in Alzheimer's Disease and Related Dementias
by: Huilin Tang, et al.
Published: (2026)

Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
by: Deep Dutta, et al.
Published: (2026)

Predictors of Exercise Performance in Type 1 Diabetes: The Role of Hypoglycaemia Fear, Glycaemic Control, and Vascular Health: A Retrospective Cross‐Sectional Study
by: Arne Kooistra, et al.
Published: (2026)

Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset
by: Hannah Wallace, et al.
Published: (2026)

The 1‐Hour Plasma Glucose for Early Risk Stratification in Young, Obese Chinese Adults: Implications for Clinical Management
by: Miaomiao Yuan, et al.
Published: (2026)

Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study
by: Kuo‐En Chen, et al.
Published: (2026)

Glycemic Variability Bridges Time in Range and Time in Tight Range: A Unified Equation for Both Type 1 and Type 2 Diabetes Based on Large‐Scale Continuous Glucose Monitoring Data
by: Yuan Yao, et al.
Published: (2026)

Artificial Intelligence in Screening and Grading Diabetic Eye Diseases: A Systematic Review From Algorithms to Clinic
by: Jiamin Zhou, et al.
Published: (2026)

Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology
by: Qi Zeng, et al.
Published: (2026)

Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
by: Marga A. G. Helmink, et al.
Published: (2024)

Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank
by: Sophie C. de Ruiter, et al.
Published: (2025)

HbA1c ≤ 6.5% in Early Type 2 Diabetes: Threshold, Trajectory, or Marker of Integrated Risk Management?
by: Man Sun, et al.
Published: (2026)

Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
by: John Armato, et al.
Published: (2026)

Dose–Response Effect of Glucagon on Glucose, Beta‐Cell Secretion and Metabolism in Healthy Individuals
by: Sophie Betty Brock, et al.
Published: (2026)

Glucose‐lowering medicines use before and after entry into long‐term care facilities
by: Yohanes A. Wondimkun, et al.
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2026)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2025)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2025)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2026)

Diabetes, Obesity and Metabolism
Published: (2024)

Diabetes, Obesity and Metabolism
Published: (2025)

Diabetes, Obesity and Metabolism
Published: (2025)

Diabetes, Obesity and Metabolism
Published: (2026)

Diabetes, Obesity and Metabolism
Published: (2025)

Diabetes, Obesity and Metabolism
Published: (2025)